Amedeo Smart

Free Medical Literature Service

 

Amedeo

Gastric Cancer
  Free Subscription

Articles published in
Br J Surg
    April 2024
  1. BROWN LR, Thomson GG, Gardner E, Chien S, et al
    Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znae098.
    >> Share

  2. SCHNEIDER MA, Gutschow CA
    Author response to: Comment on: Defining benchmarks for total and distal gastrectomy: global multicentre analysis.
    Br J Surg. 2024;111:znae079.
    >> Share

    January 2024
  3. LIU W, Chen X, Zhou Z, Chen Y, et al
    Reinforcement of the stapled duodenal stump during laparoscopic gastrectomy.
    Br J Surg. 2024;111:znad305.
    >> Share


  4. Erratum to: Long-term oncological outcomes of robotic versus laparoscopic gastrectomy for gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znae025.
    >> Share

  5. SCHNEIDER MA, Kim J, Berlth F, Sugita Y, et al
    Defining benchmarks for total and distal gastrectomy: global multicentre analysis.
    Br J Surg. 2024;111:znad379.
    >> Share

  6. LI ZY, Wei B, Zhou YB, Li TY, et al
    Long-term oncological outcomes of robotic versus laparoscopic gastrectomy for gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znad435.
    >> Share

    September 2023
  7. BAUSYS A, Luksta M, Anglickiene G, Maneikiene VV, et al
    Effect of home-based prehabilitation on postoperative complications after surgery for gastric cancer: randomized clinical trial.
    Br J Surg. 2023 Sep 26:znad312. doi: 10.1093.
    >> Share

    June 2023
  8. MARKAR SR, Guazzelli A, Taylor A, Jones LL, et al
    Protocol for open-label randomized clinical trial of intensive surveillance versus standard postoperative follow-up in patients undergoing surgical resection for oesophageal and gastric cancer.
    Br J Surg. 2023 Jun 28:znad180. doi: 10.1093.
    >> Share

  9. VAN DIEREN JM, van der Post RS, Bisseling TM
    Shifting perceptions on endoscopic surveillance and timing of prophylactic gastrectomy for hereditary diffuse gastric cancer.
    Br J Surg. 2023 Jun 24:znad192. doi: 10.1093.
    >> Share

    March 2023
  10. BAXTER MA, Khan KS, Gall LS, Samuelson C, et al
    Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study.
    Br J Surg. 2023;110:456-461.
    >> Share

  11. PUCHER PH, Park MH, Cromwell DA, Crosby TC, et al
    Diagnosis and treatment for gastro-oesophageal cancer in England and Wales: analysis of the National Oesophago-Gastric Cancer Audit (NOGCA) database 2012-2020.
    Br J Surg. 2023 Mar 27:znad065. doi: 10.1093.
    >> Share

    February 2023
  12. PARK SH, Hyung WJ, Yang HK, Park YK, et al
    Standard follow-up after curative surgery for advanced gastric cancer: secondary analysis of a multicentre randomized clinical trial (KLASS-02).
    Br J Surg. 2023 Feb 1:znad002. doi: 10.1093.
    >> Share

    November 2022
  13. KUROKAWA Y, Doki Y, Mizusawa J, Yoshikawa T, et al
    Five-year follow-up of a randomized clinical trial comparing bursectomy and omentectomy alone for resectable gastric cancer (JCOG1001).
    Br J Surg. 2022 Nov 12. pii: 6825225. doi: 10.1093.
    >> Share

    August 2022
  14. SILVA ANS, Saito Y, Yoshikawa T, Oshima T, et al
    Author response to: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
    Br J Surg. 2022;109:e106.
    >> Share

  15. LIU K, Hu JK
    Comment on: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
    Br J Surg. 2022;109:e105.
    >> Share

    July 2022
  16. LIU K, Zhang WH, Hu JK
    Comment on: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.
    Br J Surg. 2022;109:e91.
    >> Share

  17. RAHMAN SA, Underwood TJ
    Author response to: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.
    Br J Surg. 2022;109:e92.
    >> Share

    February 2022
  18. SILVA ANS, Saito Y, Yoshikawa T, Oshima T, et al
    Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
    Br J Surg. 2022;109:291-297.
    >> Share

  19. RAHMAN S, Thomas B, Maynard N, Park MH, et al
    Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.
    Br J Surg. 2022;109:227-236.
    >> Share

    November 2021
  20. RAHMAN SA, Maynard N, Trudgill N, Crosby T, et al
    Prediction of long-term survival after gastrectomy using random survival forests.
    Br J Surg. 2021;108:1341-1350.
    >> Share

    October 2021
  21. CHMELO J, Phillips AW, Greystoke A, Bradshaw A, et al
    Comparison of the effects of FLOT and ECX chemotherapy for oesophagogastric adenocarcinoma on cardiopulmonary reserve.
    Br J Surg. 2021;108:e328-e329.
    >> Share

    September 2021
  22. ZHENG-YAN L, Feng Q, Yan S, Ji-Peng L, et al
    Learning curve of robotic distal and total gastrectomy.
    Br J Surg. 2021;108:1126-1132.
    >> Share

  23. BONNOT PE, Lintis A, Mercier F, Benzerdjeb N, et al
    Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study).
    Br J Surg. 2021 Sep 9. pii: 6366963. doi: 10.1093.
    >> Share

  24. PARK DJ, Kim YW, Yang HK, Ryu KW, et al
    Short-term outcomes of a multicentre randomized clinical trial comparing laparoscopic pylorus-preserving gastrectomy with laparoscopic distal gastrectomy for gastric cancer (the KLASS-04 trial).
    Br J Surg. 2021 Sep 6. pii: 6364812. doi: 10.1093.
    >> Share

    June 2021
  25. ALKHAFFAF B, Metryka A, Blazeby JM, Glenny AM, et al
    Core outcome set for surgical trials in gastric cancer (GASTROS study): international patient and healthcare professional consensus.
    Br J Surg. 2021 Jun 24. pii: 6308782. doi: 10.1093.
    >> Share

  26. PHILLIPS AW, Griffin SM
    Three decades of oesophagogastric cancer care: now a curable disease.
    Br J Surg. 2021;108:595-597.
    >> Share

    May 2021
  27. JIN C, Jiang Y, Yu H, Wang W, et al
    Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer.
    Br J Surg. 2021;108:542-549.
    >> Share

    March 2021
  28. KOEMANS WJ, van der Kaaij RT, van Sandick JW
    Reply to Correspondence to "Treatment of PERItoneal dissemination in Stomach Cancer patients with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy (HIPEC): first results of the PERISCOPE I study".
    Br J Surg. 2021;108:e94.
    >> Share

  29. CHIU CC, Lee PH, Chang CS, Rau KM, et al
    Correspondence to 'Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results'.
    Br J Surg. 2021;108:e93.
    >> Share

    January 2021
  30. KAMARAJAH SK, Navidi M, Phillips AW
    Response to "Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer".
    Br J Surg. 2021 Jan 31. pii: 6124825. doi: 10.1093.
    >> Share

  31. HU Q, Sun Y, Yang X
    Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer.
    Br J Surg. 2021 Jan 31. pii: 6124822. doi: 10.1093.
    >> Share

    November 2020
  32. LIU Y, Yang T, Wei YW
    What is the difference between overall survival, recurrence-free survival and time-to-recurrence?
    Br J Surg. 2020;107:e634.
    >> Share

    October 2020
  33. HUANG J, Yang B, Tan J, Zhou S, et al
    Gastric cancer nodal tumour-stroma ratios influence prognosis.
    Br J Surg. 2020 Oct 14. doi: 10.1002/bjs.12054.
    >> Share

  34. JESTIN HANNAN C, Linder G, Kung CH, Johansson J, et al
    Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.
    Br J Surg. 2020;107:1500-1509.
    >> Share

  35. VAN DER KAAIJ RT, Wassenaar ECE, Koemans WJ, Sikorska K, et al
    Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results.
    Br J Surg. 2020;107:1520-1528.
    >> Share

    September 2020
  36. JIN C, Jiang Y, Yu H, Wang W, et al
    Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer.
    Br J Surg. 2020 Sep 29. doi: 10.1002/bjs.11928.
    >> Share

    August 2020
  37. LIN JP, Zhao YJ, He QL, Hao HK, et al
    Adjuvant chemotherapy for patients with gastric neuroendocrine carcinomas or mixed adenoneuroendocrine carcinomas.
    Br J Surg. 2020;107:1163-1170.
    >> Share

    February 2020
  38. LU J, Zhao YJ, Zhou Y, He Q, et al
    Modified staging system for gastric neuroendocrine carcinoma based on American Joint Committee on Cancer and European Neuroendocrine Tumor Society systems.
    Br J Surg. 2020;107:248-257.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016